XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.3
INVESTMENTS IN EQUITY SECURITIES (Tables)
 9 Months Ended
Sep. 30, 2025
Schedule of Investments [Abstract]  
SCHEDULE OF INVESTMENTS

The following table summarizes the Company’s investments for the periods presented:

 

   September 30, 2025   December 31, 2024 
   Carrying Amount   Economic Interest   Carrying Amount   Economic Interest 
Equity Method Investments                    
ChemoMouthpiece, LLC  $4,928,226    6.59%  $5,172,242    6.59%
SI Healthcare Technologies, LLC   47,976    50.00%   40,703    50.00%
Biomimetic Innovations Limited   6,612,274    9.68%   -    -%
Total Equity Method Investments  $11,588,476        $5,212,945      
                     
Cost Method Investments                    
Direct Dermatology Inc.  $1,000,000        $1,000,000      
Total Cost Method Investments  $1,000,000        $1,000,000      
                     
Total Investments  $12,588,476        $6,212,945      
SCHEDULE OF LOSS FROM EQUITY METHOD INVESTMENT

The following table summarizes the Company’s share of income (loss) from equity method investments reflected in the Company’s Consolidated Statements of Operations for the periods presented:

 

   2025   2024   2025   2024 
  

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
   2025   2024   2025   2024 
Equity Method Investments                    
ChemoMouthpiece, LLC  $(89,531)  $(31,448)  $(244,015)  $(31,448)
SI Healthcare Technologies, LLC   -    -    7,273    - 
Biomimetic Innovations Limited   (199,111)   -    (390,990)   - 
Total  $(288,642)  $(31,448)  $(627,732)  $(31,448)